Published in J Comput Aided Mol Des on December 01, 2002
Molecular dynamics: survey of methods for simulating the activity of proteins. Chem Rev (2006) 3.18
Protein flexibility in docking and surface mapping. Q Rev Biophys (2012) 0.96
The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design. BMC Microbiol (2011) 0.91
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis. PLoS One (2011) 0.88
Purification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae. BMC Microbiol (2007) 0.86
Crystallization and preliminary X-ray study of a thermostable alanine racemase from Thermoanaerobacter tengcongensis MB4. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.76
Characterization and preliminary mutation analysis of a thermostable alanine racemase from Thermoanaerobacter tengcongensis MB4. Extremophiles (2013) 0.76
All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00
Fluctuation and cross-correlation analysis of protein motions observed in nanosecond molecular dynamics simulations. J Mol Biol (1995) 2.39
Developing a dynamic pharmacophore model for HIV-1 integrase. J Med Chem (2000) 1.71
Determination of the structure of alanine racemase from Bacillus stearothermophilus at 1.9-A resolution. Biochemistry (1997) 1.59
Suicide substrates for the alanine racemase of Escherichia coli B. Biochemistry (1978) 1.47
Identification of common functional configurations among molecules. J Chem Inf Comput Sci (1996) 1.45
Recent developments in structure-based drug design. J Mol Med (Berl) (2000) 1.41
Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D. Chem Biol (1997) 1.35
Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. J Pharm Sci (1987) 1.23
Reaction of alanine racemase with 1-aminoethylphosphonic acid forms a stable external aldimine. Biochemistry (1998) 1.16
Structure of a Michaelis complex analogue: propionate binds in the substrate carboxylate site of alanine racemase. Biochemistry (1999) 1.12
On the similarity of properties in solution or in the crystalline state: a molecular dynamics study of hen lysozyme. J Biomol NMR (2000) 1.02
Mutant analysis shows that alanine racemases from Pseudomonas aeruginosa and Escherichia coli are dimeric. J Bacteriol (2002) 0.97
A model for enzyme-substrate interaction in alanine racemase. J Am Chem Soc (2001) 0.88
BUILDER v.2: improving the chemistry of a de novo design strategy. J Comput Aided Mol Des (1995) 0.83
Towards the automatic design of synthetically accessible protein ligands: peptides, amides and peptidomimetics. J Comput Aided Mol Des (1996) 0.81
Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling. J Med Chem (2009) 1.28
Charge-charge interactions are key determinants of the pK values of ionizable groups in ribonuclease Sa (pI=3.5) and a basic variant (pI=10.2). J Mol Biol (2003) 1.26
Molecular dissection of a critical specificity determinant within the amino acid editing domain of leucyl-tRNA synthetase. Biochemistry (2004) 1.11
The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site. Biochemistry (2005) 1.11
Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants. Biophys J (2005) 1.04
Prediction of HIV-1 integrase/viral DNA interactions in the catalytic domain by fast molecular docking. J Med Chem (2004) 1.04
Brownian dynamics simulations of the recognition of the scorpion toxin P05 with the small-conductance calcium-activated potassium channels. J Mol Biol (2002) 1.02
Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels. Biophys J (2002) 1.00
Electrostatic steering at acetylcholine binding sites. Biophys J (2006) 0.94
Computed pore potentials of the nicotinic acetylcholine receptor. Biophys J (2006) 0.89
Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors. J Med Chem (2005) 0.89
Nucleotide modification at the gamma-phosphate leads to the improved fidelity of HIV-1 reverse transcriptase. Nucleic Acids Res (2005) 0.89
Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain. Biophys J (2005) 0.88
Molecular modeling study of the editing active site of Escherichia coli leucyl-tRNA synthetase: two amino acid binding sites in the editing domain. Proteins (2004) 0.87
pK values of histidine residues in ribonuclease Sa: effect of salt and net charge. J Mol Biol (2003) 0.86
Comparative molecular dynamics simulations of HIV-1 integrase and the T66I/M154I mutant: binding modes and drug resistance to a diketo acid inhibitor. Proteins (2005) 0.85
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance. Biophys J (2003) 0.84
The association between a negatively charged ligand and the electronegative binding pocket of its receptor. Biopolymers (2002) 0.84
Molecular docking and 3D-QSAR studies on gag peptide analogue inhibitors interacting with human cyclophilin A. J Med Chem (2002) 0.84
Dynamic pharmacophore model optimization: identification of novel HIV-1 integrase inhibitors. J Med Chem (2006) 0.83
Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations. Biophys J (2007) 0.83
Molecular dynamics studies of alanine racemase: a structural model for drug design. Biopolymers (2003) 0.82
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors. Bioorg Med Chem Lett (2004) 0.82
Modulation of substrate specificity within the amino acid editing site of leucyl-tRNA synthetase. Biochemistry (2007) 0.81
Cluster analysis of water molecules in alanine racemase and their putative structural role. Protein Eng Des Sel (2004) 0.81
Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior. J Neurosci (2013) 0.81
Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease. Proteins (2011) 0.80
Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates. Proteins (2009) 0.80
Charge-charge interactions are the primary determinants of the pK values of the ionizable groups in Ribonuclease T1. Biophys Chem (2002) 0.77
Interactions of acetylcholine binding site residues contributing to nicotinic acetylcholine receptor gating: role of residues Y93, Y190, K145 and D200. J Mol Graph Model (2013) 0.77
Hybrid quantum mechanical/molecular mechanical molecular dynamics simulations of HIV-1 integrase/inhibitor complexes. Biophys J (2007) 0.77
Associations between the Rho kinase-1 catalytic and PH domain regulatory unit. J Mol Graph Model (2013) 0.76
Nucleophile activation in PD...(D/E)xK metallonucleases: an experimental and computational pK(a) study. J Inorg Biochem (2010) 0.76
Pharmacophore-based virtual screening to aid in the identification of unknown protein function. Chem Biol Drug Des (2012) 0.76
Efficient 3D database screening for novel HIV-1 IN inhibitors. J Chem Inf Comput Sci (2004) 0.75
New insights into the binding and catalytic mechanisms of Bacillus thuringiensis lactonase: insights into B. thuringiensis AiiA mechanism. PLoS One (2013) 0.75
Molecular dynamics simulations of Factor Xa: insight into conformational transition of its binding subsites. Biopolymers (2008) 0.75
Cluster analysis of hydration waters around the active sites of bacterial alanine racemase using a 2-ns MD simulation. Biopolymers (2008) 0.75
Molecular modeling of enzyme attachment on AFM probes. J Mol Graph Model (2013) 0.75
Biophysical characteristics of cholera toxin and Escherichia coli heat-labile enterotoxin structure and chemistry lead to differential toxicity. J Phys Chem B (2014) 0.75